<?xml version='1.0' encoding='utf-8'?>
<document id="31723039"><sentence text="Targeting redox heterogeneity to counteract drug tolerance in replicating Mycobacterium tuberculosis." /><sentence text="The capacity of Mycobacterium tuberculosis (Mtb) to tolerate multiple antibiotics represents a major problem in tuberculosis (TB) management" /><sentence text=" Heterogeneity in Mtb populations is one of the factors that drives antibiotic tolerance during infection" /><sentence text=" However, the mechanisms underpinning this variation in bacterial population remain poorly understood" /><sentence text=" Here, we show that phagosomal acidification alters the redox physiology of Mtb to generate a population of replicating bacteria that display drug tolerance during infection" /><sentence text=" RNA sequencing of this redox-altered population revealed the involvement of iron-sulfur (Fe-S) cluster biogenesis, hydrogen sulfide (H2S) gas, and drug efflux pumps in antibiotic tolerance"><entity charOffset="77-81" id="DDI-PubMed.31723039.s6.e0" text="iron" /><entity charOffset="82-88" id="DDI-PubMed.31723039.s6.e1" text="sulfur" /><entity charOffset="116-132" id="DDI-PubMed.31723039.s6.e2" text="hydrogen sulfide" /><entity charOffset="134-137" id="DDI-PubMed.31723039.s6.e3" text="H2S" /><pair ddi="false" e1="DDI-PubMed.31723039.s6.e0" e2="DDI-PubMed.31723039.s6.e0" /><pair ddi="false" e1="DDI-PubMed.31723039.s6.e0" e2="DDI-PubMed.31723039.s6.e1" /><pair ddi="false" e1="DDI-PubMed.31723039.s6.e0" e2="DDI-PubMed.31723039.s6.e2" /><pair ddi="false" e1="DDI-PubMed.31723039.s6.e0" e2="DDI-PubMed.31723039.s6.e3" /><pair ddi="false" e1="DDI-PubMed.31723039.s6.e1" e2="DDI-PubMed.31723039.s6.e1" /><pair ddi="false" e1="DDI-PubMed.31723039.s6.e1" e2="DDI-PubMed.31723039.s6.e2" /><pair ddi="false" e1="DDI-PubMed.31723039.s6.e1" e2="DDI-PubMed.31723039.s6.e3" /><pair ddi="false" e1="DDI-PubMed.31723039.s6.e2" e2="DDI-PubMed.31723039.s6.e2" /><pair ddi="false" e1="DDI-PubMed.31723039.s6.e2" e2="DDI-PubMed.31723039.s6.e3" /></sentence><sentence text=" The fraction of the pH- and redox-dependent tolerant population increased when Mtb infected macrophages with actively replicating HIV-1, suggesting that redox heterogeneity could contribute to high rates of TB therapy failure during HIV-TB coinfection" /><sentence text=" Pharmacological inhibition of phagosomal acidification by the antimalarial drug chloroquine (CQ) eradicated drug-tolerant Mtb, ameliorated lung pathology, and reduced postchemotherapeutic relapse in in vivo models"><entity charOffset="81-92" id="DDI-PubMed.31723039.s8.e0" text="chloroquine" /><entity charOffset="94-96" id="DDI-PubMed.31723039.s8.e1" text="CQ" /><pair ddi="false" e1="DDI-PubMed.31723039.s8.e0" e2="DDI-PubMed.31723039.s8.e0" /><pair ddi="false" e1="DDI-PubMed.31723039.s8.e0" e2="DDI-PubMed.31723039.s8.e1" /></sentence><sentence text=" The pharmacological profile of CQ (Cmax and AUClast) exhibited no major drug-drug interaction when coadministered with first line anti-TB drugs in mice"><entity charOffset="32-33" id="DDI-PubMed.31723039.s9.e0" text="CQ" /></sentence><sentence text=" Our data establish a link between phagosomal pH, redox metabolism, and drug tolerance in replicating Mtb and suggest repositioning of CQ to shorten TB therapy and achieve a relapse-free cure"><entity charOffset="135-136" id="DDI-PubMed.31723039.s10.e0" text="CQ" /></sentence><sentence text="" /></document>